chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Passed away; Arm hurt bad; She could barely eat/drink; She could barely do anything; Diarrhea; Nausea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DEATH (Passed away) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (had COVID in December 2020.) in December 2020.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm hurt bad), DECREASED APPETITE (She could barely eat/drink), ASTHENIA (She could barely do anything), DIARRHOEA (Diarrhea), NAUSEA (Nausea) and VOMITING (Vomiting). On 24-Jan-2021, PAIN IN EXTREMITY (Arm hurt bad), DECREASED APPETITE (She could barely eat/drink), ASTHENIA (She could barely do anything), DIARRHOEA (Diarrhea), NAUSEA (Nausea) and VOMITING (Vomiting) had resolved. The patient died on an unknown date. The cause of death was not reported. It is unknown if an autopsy was performed.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medications were not reported. Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Death event added.; Sender's Comments: This case refers to a 73-year-old female patient with a history of COVID-19 infection one month prior to receiving mRNA-1273 who died after unknown duration after the vaccination. Based on the current available information and temporal association between the use of the product mRNA-1273 and the remaining events, a causal relationship cannot be excluded.; Reported Cause(s) of Death: Unknown cause of death
I had two of those shots. I still got shingles/suspected vaccination failure; felt like bad sunburn; internal stabbing pains; shingles/still got shingles/affected area spread until it was my left breast, up b to my shoulder, and over to my armpit; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingles vaccine (had the old shot).   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, burning sensation and pain. On an unknown date, the outcome of the vaccination failure, burning sensation and pain were unknown and the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the vaccination failure, shingles, burning sensation and pain to be related to Shingrix and Shingrix.     Additional Information: GSK receipt date: 28-Feb-2023 Reporter's comment: The case was received from the patient via interactive digital media. The patient received two shots of Shingrix when it came out and still got shingles but not nearly as bad as they could had been according to his/her physician. The patient reported that it felt like bad sunburn, then internal stabbing pains and also, the affected area spread until it was his/her left breast, up to his/her shoulder, and over to his/her armpit.  The patient's skin looked normal, no rash or redness.  It took 3 months to totally clear up. The patient had recommend the vaccines, had no side effects from them. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available. As it was reported that it took 3 months to totally clear up therefore for shingles outcome was captured as recovered.
About six hours after DAPTACEL. Pt developed rash at site, red, warm, c/o itching. Referred to Dr. on 9/25/09 and appears that it might be fading. Con. to c/o itching 4 cm diam. R leg.
Mother said 2 days after the vaccines were given she noticed there was a large amount of swelling at the site (about 2 1/2 inches). He never complained of pain. Did not have a fever. Only redness and swelling. Dr advised warm compresses. Did not cause her to miss any school.
Patient had syncopal episode and fell from seated position in a chair. Patient lost consciousness and had a bloody nose. EMS Standby assisted patient and took vital signs on patient. Vital signs and 4 lead EKG were taken and found to be within normal limits for the patient. The patient stated he has history of syncopal episodes after receiving vaccines/injections. 911 was called for the local fire/rescue department to transport the patient to the hospital.
I experienced headaches following each innoculation with Hep B. I also began having severe skin problems (acne and other facial/neck marks) following vaccination.
Throat became tight; heart rate slightly elevated; eyes began to water; nausea; extremely cold/shivering; voice hoarse (most likely from throat tightness); difficulty swallowing.
Pt recv vax on 2/1/99; on 2/25/99 pt exp rash on abdominal area, vesicular papules on scalp, face, back, abdomen
1/24; evening sore 1/25; sore, swollen, red-patchy (2"x3") 1/28; normal 1/30; follow-up - recovering.
CHILLS; HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805022, and batch number: 1805022 expiry: UNKNOWN) .5 ml, administered on 06-MAR-2021 04:00 to Left Arm for prophylactic vaccination. No concomitant medications were reported.  On MAR-2021, the subject experienced chills. On MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and had not recovered from headache. This report was non-serious.
fatigue, fever, chills, headache, myalgia for 3 days fatigue, low grade temperature, chills, and headache for 9 days
48 hrs p/DTP #4 t=105, feb sz (simple);Had 1 previous feb sz JAN91 w/viral infect;
Severe body and joint pain; Severe body and joint pain; hard to move; dizziness; temp over 101; headache; This is a spontaneous report from a contactable nurse (patient). A 44-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 intramuscular, administered in the left arm on 08Jul2021 at 16:00 (Batch/Lot Number: EW0185) as dose 1, single for Covid-19 immunisation. Medical history included a history (hx) of head injury from 1995 to an unknown date and known allergies to Sulfa. Concomitant medications included naproxen sodium (ALEVE) taken for an unspecified indication, start and stop date were not reported; cetirizine hydrochloride (ZYTREC) taken for an unspecified indication, start and stop date were not reported; mometasone furoate (FLONASE [MOMETASONE FUROATE]) taken for an unspecified indication, start and stop date were not reported; spironolactone (SPIRONOLACTONE) taken for an unspecified indication, start and stop date were not reported. The patient had no other vaccine in four weeks. The patient had no Covid prior vaccination and was not tested post vaccination. The patient experienced severe body and joint pain so bad it was hard to move (literally every little joint), dizziness, temp over 101, and headache on 09Jul2021 at 06:00. No treatment was administered for the events. The outcome of the events was resolving.   No follow up attempts are possible. No further information is expected.
1 day after Menactra dose (8-2-07) patient complained of vertigo and tingling feet. 2 days after vaccine she had a syncopal event. Admitted for diagnostic studies. 8/27/07-records received for DOS 8/4-8/6/07- DC DX: Depression. Dizziness. Asthma. Presented to ED after syncopal episode. C/O dizziness and tingling of feet for 3 days. Seen in another ED and diagnosed with vertigo. Now C/O feeling her hands heavy and headaches. In ED orthostatic heart rate 90 sitting to 120 while standing. . Upon exit from ER felt acutely dizzy and admitted for observation.  Normal neurological exam. Her symptoms could be explained by a viral illness causing orthostatsis which could also explain her arm and leg tingling. The recent increase in the dose of Prozac is a possible etiology. Possible reaction to vaccine
Immediately I had tingling down my arm, into my fingers and in my left calf muscle and toes. The sensation varied from tingling to small shooting pains. The feeling eventually happened in my whole left leg and whole left arm. I felt a pressure or tension sensation in my upper arm most of the day. I would wake up with my left leg and arm feeling puffy and slightly swollen, and of course tingly or throbbing in pain. This lasted for about 3 weeks. After the 3 weeks, for a week now, I have had pressure in my left hand and upper arm and tingling with shooting pains maybe once a day rather than constantly or dozens of times a day.
Information has been received from a licensed practical nurse referring to 9 patients of unknown age and gender. There was no medical history or concurrent condition reported. On unknown dates the 9 patients were inadvertently vaccinated with VARIVAX (Merck) (dosage, strength, route and lot# were not reported), which had been improperly stored. There was no concomitant medication reported. At the time of the report, no adverse effects was reported. This is one of several reports received from the same reporter. Additional information is not expected as the reporter was not consented to be contacted.
After receiving the vaccine my left arm was sore. When I tried lifting my arm it was sore and felt weak or stiff. The gland in my armpit was sore and had bumped up. The more I tried using the arm it started to get better. By the end of the day I could ease my arm up and use it. The soreness was gone by the next day. I started to get a rash around April. I had red bumps that itch around my lower legs, eyes, and possibly my arms too. I got a prescription for it. It never went completely away around my inner knee. Around August and September the rash had came back even worse on my lower legs and arms, but it was not on my face. It was really red, bumpy, and itchy. I tried anti-itch creams , Benadryl, alcohol, and other stuff to try to help it. I tried some hand sanitizer that had CBD oil in it and that helped the most. I was prescribed Prednisone 20mg on September 9th for a 7 day supply. I also had a prescription for something else similar to Benadryl as well. I was also prescribed azithromycin 250mg tablets on  September 10th  for 5 days. Then I had caught covid in November. I had a persistent bad cough  with no phlegm just a lot of coughing. I could cough for about 5 minutes straight when I went into a coughing spell.  That only happened twice. I was taking cough drops as well. I also had a sore throat. I took Augmentin for that. I also had fatigue, and I still have that now. I also have a hard time staying awake. I also wasn't allergic to bee stings before but then I got stung on  October 5th 2021 and then I became allergic to bees. My arm was extremely swelled up and red. It hurt where the sting was. My skin was hot to the touch. I got stung in both arms so both arms were like that. It lasted a couple of days so I went to the ER. They gave me medicine and it cleared up.
heart attack; postherpetic neuralgia; dizziness; herpes zoster; Information has been received from a lawyer concerning a case in litigation and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapy were not reported. On an unknown date the patient was inoculated with zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). After receiving zoster vaccine live (ZOSTAVAX), patient suffered from: herpes zoster, postherpetic neuralgia, heart attack, and dizziness. As a result of these symptoms, patient was seen and treated by medical providers and is still under their care. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), Patient's symptoms have resulted in physical limitations not present prior to using zoster vaccine live (ZOSTAVAX). Patient also experience mental and emotional distress due to resulting physical limitations and seriousness of patient's condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), patient sustained severe and permanent personal injuries. Further, as a tragic consequence of company's wrongful conduct, patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of company's conduct, patient have suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events was not recovered. The events were considered to be related to zoster vaccine live (ZOSTAVAX).  Upon internal review, the event of heart attack was determined to be medically significant.
Information has been received from a nurse practitioner concerning a 2 month old female who was vaccinated with a first dose of COMVAX (0.5 mL). Subsequently, the patient developed meningitis (unspecified if bacterial or viral) and was hospitalized. The patient was diagnosed and given an "antibiotic to cure the problem." The physician at the hospital stated that the patient should not receive any more COMVAX. At the time of the report the patient was recovering. Additional information has been requested.
4cm X 5cm erythematous, warm, indurated area on right lateral thigh, scattered red papules over legs, abdomen and arms.
Rash erythematous. Itchy rash. From initial information received on 09/Apr/2003 from a public health facility regarding an adverse event occurring in the USA, it was reported that a 15 month old male patient received Daptacel, lot number C0950AB, intra-muscularly in the right arm and Comvax, lot number 0737M, manufactured by Merck, administered intra-muscularly in the left arm on 08/Apr/2003 at 6:10PM. Approximately 30 minutes later the patient developed a patchy red, itchy rash on his nose, ears, neck and upper back. He reportedly did not experience any respiratory distress and his skin was warm and dry. He was seen in a hospital emergency room. There was no known past medical history and it was not known whether the child had any illnesses at the time of vaccination. Reportedly, the child recovered. The reporting facility of this case is the same reporting facility as for case 2003-00819
1 hour after 2nd shot developed hives on neck, shoulder and back.  Last approx 6 hours. No hives were experienced after the 1st shot.
pt states he was achy next day after getting vax.  Next day he noticed a red, itchy rash on left shoulder around the injection site.  Pt has not contacted his PCP at this time.  He still has the rash at this time but it has not gotten any worse.
Every time (except once) I receive any type of flu vaccination I get the flu; not just mild symptoms, but the actual sickness.
Severe headache, painful inflamed left lymph nodes, painful inflamed joints specially fingers and knees, body aches throughout, legs? skin painful when clothes rubbed and lack of energy. Today is the 3rd after the booster and I still woke up with an headache which I rarely get and lymph nodes are still very sore and inflamed.
Pain, redness, swelling, size 4 x 3 in., hot patient said he felt "woozy, feverish & weakness". Pt has low grade fever, & slight hypertension. Tx: BENADRYL, pain pills.
Delayed Cutaneous Hypersensitivity: Rash developed on all parts of the body.  Rash started on the upper arms and upper sides.  Rash always appeared symmetrically on my body.  Rash did not cover the whole body at once.  It covered about 10% of my body for hours and then move to other spots, always symmetrically.  At times there appeared hives also on parts of my body I'd scratch.  Only parts of my body not affected were the soles of my feet, palms of my hands, and from mouth above on my face.
Received shot 7 PM, at 3 AM woke with 102.5. Fever, chills and abnormally high BP and heart rate. Called 911. EM arrived and diagnosed reaction and advised hospital. Patient developed severe gastroenteritis. Lasting one week.
- Mild headache throughout about 12 hours after vaccine administration and lasted about 24 hours - slight fever after about 12 hours but subsided - major body aches about 12 hours after vaccine administration and lasted a little over 24 hours.
Fever, pain, fatigue, migraine, red rash down my right arm today, hives, itching, Today I still have a large hive like rash on my right arm very itchy.
Injection site pain, headache and chills. Injection site is still painful and sore. Still have headache, no medication. Chills stopped by this morning. No medication taken for pain.
2 minutes after receiving vaccine; felt lightheaded and dizzy. His blood pressure was completely normal. He never has had this happen before. The dizziness resolved after 15 minutes.
Vaccines were stored after beyond use date and CDC expiry date; Vaccine was administered after beyond use date and CDC expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was administered after beyond use date and CDC expiry date) and PRODUCT STORAGE ERROR (Vaccines were stored after beyond use date and CDC expiry date) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 068H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 08-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 08-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was administered after beyond use date and CDC expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccines were stored after beyond use date and CDC expiry date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was administered after beyond use date and CDC expiry date) and PRODUCT STORAGE ERROR (Vaccines were stored after beyond use date and CDC expiry date) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  It was reported that the vial was stored in standard freezer for the lot 068H21A with 2 degrees F high -1 degrees F low on 04-Jan-2022.  The beyond use date and CDC expiry date was reported as 02-Apr-2022.  No treatment information was provided by the reporter.  This case contains information for the thirtieth of 45 patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-571126 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-571126:Master Case
Hives/rash, itchy bumps like bugs bites. Elbows, forearms,  lower legs, hand/fingers, feet.
She is having pain on the inside of her left ankle. She does not have the pain when she elevates her leg.  She also is having trouble standing on her left foot.
Pt. had Hep A and Menactra vaccine. Left with mother and father. Fainted in elevator, brought back into exam room by parents. Laid down on floor, vss, became alert, verbal, responsive, EMS transported pt. to ER per parents request, 911 had been called.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a elderly female patient who received SHINGRIX for prophylaxis. The patient's past medical history included shingles (prior to getting the vaccine she had several outbreaks of shingles.). Concurrent medical conditions included tremor (essential diagnosed when she was 30 years old). On an unknown date, the patient received the 1st dose of SHINGRIX (intramuscular). On an unknown date, unknown after receiving SHINGRIX, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient has experienced a little soreness in her arm. The reporter consented to follow up. For tolerance to the 2nd dose of SHINGRIX, refer case US2019057139.
second shot, 3/17, next day muscle aches and sleeping 3/18. on 3/19 sinus flared up with headaches, sore throat, swollen glands, ear aches and yellow discharge from sinus
Night of vaccine, I woke up at about 4am experiencing chills and a headache. Headache and minor chills still remain as well as fever, aches, fatigue, and weakness.
Noted redness and swelling left shoulder. 2 day after injec. of DTaP
Shaking, chills, 105.4 fever, extreme fatigue, body aches. The fever, body aches, chills and sweating were about a day and a half long. The fatigue lasted almost a full week. It all hit me at once, at 01:30AM 06/17, I went into the hospital that day. I couldn't bring my fever down. The hospital confirmed it was just the vaccine. I had low blood pressure 88/73. I was given a bag of IV fluids and treatment for a bad headache I had. Tylenol for my fever. Over the course of being in the hospital my fever went down and blood pressure became more stable. I was released to go back home after about 3 hours.
When they filled the needle in the vial, it was left off for four days laying underneath the box; When they filled the needle in the vial, it was left off for four days laying underneath the box; Sore arm; Feeling tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 04Mar2022 (Lot number: FK9896, Expiration Date: 30Jun2022) at the age of 75 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "COPD" (unspecified if ongoing); "Bronchitis" (unspecified if ongoing), notes: Bronchitis; "High cholesterol" (unspecified if ongoing); "Arthritis" (unspecified if ongoing); "Pneumonia" (unspecified if ongoing); "High Blood Pressure" (unspecified if ongoing), notes: High Blood Pressure; "Acid Reflux" (unspecified if ongoing); "Herniated Slipped disk" (unspecified if ongoing), notes: Herniated Slipped disk; "COVID" (unspecified if ongoing), notes: COVID; "Pain" (unspecified if ongoing). Concomitant medication(s) included: ALPRAZOLAM; OXYBUTYNIN; FUROSEMIDE; LISINOPRIL; VITAMIN C [ASCORBIC ACID]; VITAMIN D [COLECALCIFEROL]; MONTELUKAST; CENTRUM SILVER [ASCORBIC ACID;BETACAROTENE;BIOTIN;CALCIUM;CHROMIUM;COLECALCIFEROL;COPPER;FOLIC ACID;IODINE;IRON;LYCOPENE;MAGNESIUM;MANGANESE;NICOTINAMIDE;PANTOTHENIC ACID;PHOSPHORUS;PHYTOMENADIONE;POTASSIUM;PYRIDOXINE HYDROCHLORIDE;RETINOL;RIBOFLAVIN; SIMVASTATIN; TYLENOL taken for pain; METOPROLOL; ESOMEPRAZOLE MAGNESIUM. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Mar2022, outcome "recovered" (Mar2022), described as "Sore arm"; FATIGUE (non-serious) with onset Mar2022, outcome "unknown", described as "Feeling tired"; PRODUCT ADMINISTRATION ERROR (non-serious), POOR QUALITY PRODUCT ADMINISTERED (non-serious) all with onset 04Mar2022, outcome "unknown" and all described as "When they filled the needle in the vial, it was left off for four days laying underneath the box". Therapeutic measures were not taken as a result of pain in extremity.  Follow-Up (29Mar2022): Follow-up attempts are completed. No further information is expected.